Money · Wednesday 21 October 2026 · story 1
OpenAI acquires Orchestra Bio for Rosalind life sciences work
TechCrunch reports OpenAI acquired Orchestra Bio, an AI biotech software startup. OpenAI says Orchestra’s team and technology will work on Rosalind and Rosalind Workbench for life sciences research.
Why it matters. It points to more OpenAI software for pharma and life sciences work through Rosalind and Rosalind Workbench.
Read the original at techcrunch.com